| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |